Loading…

Randomized controlled study of pain education in patients receiving radiotherapy for painful bone metastases

•Short-course radiotherapy ameliorates pain of bone metastases in the majority of patients.•A pain education program for patients treated with radiotherapy for painful bone metastases results in more pain control compared to usual care.•A nurse-led pain education program on pain control and quality...

Full description

Saved in:
Bibliographic Details
Published in:Radiotherapy and oncology 2023-08, Vol.185, p.109687-109687, Article 109687
Main Authors: Geerling, Jenske I., van der Linden, Yvette M., Raijmakers, Natasja J.H., Vermeulen, Karin M., Mul, Veronique E.M., de Nijs, Ellen J.M., Westhoff, Paulien G, de Bock, Geertruida H., de Graeff, Alexander, Reyners, Anna K.L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Short-course radiotherapy ameliorates pain of bone metastases in the majority of patients.•A pain education program for patients treated with radiotherapy for painful bone metastases results in more pain control compared to usual care.•A nurse-led pain education program on pain control and quality of life can benefit patients with pain due to cancer. Although short-course radiotherapy is an effective treatment for patients with painful bone metastases, pain is not always sufficiently controlled. We therefore investigated the additional effect of a nurse-led pain education program on pain control and quality of life (QoL). In this multicenter study, patients with solid tumor bone metastases and a worst pain intensity of ≥5 on a 0–10 numeric rating scale (NRS) were randomized between care as usual (control-group) and care as usual plus the Pain Education Program (PEP-group). PEP consisted of a structured interview and personalized education with follow-up phone calls. Patients completed the Brief Pain Inventory, EORTC QLQ-C15-PAL and BM22 at week 0, 1, 4, 8 and 12. The primary outcome was pain control, defined as the number of patients whose worst pain intensity was
ISSN:0167-8140
1879-0887
DOI:10.1016/j.radonc.2023.109687